PEPTIDES FOR TREATMENT OF SEPSIS AND CANCER

The present invention provides oligopeptidic compounds comprising a first oligopeptidic component derived from SLAMF1 and a second oligopeptidic component which is a cell-penetrating peptide. The oligopeptidic compounds provided have been found unexpectedly to block signalling from TLR4, TLR7, TLR8...

Full description

Saved in:
Bibliographic Details
Main Authors YURCHENKO, Maria, HUSEBYE, Harald, ESPEVIK, Terje
Format Patent
LanguageEnglish
French
German
Published 19.04.2023
Subjects
Online AccessGet full text

Cover

Loading…